Associate Professor of Biology Martin Wu has been awarded funding from the Global Infectious Diseases Institute for his research on a point-of-care diagnostic test for COVID-19. As described in today's issue of UVAToday, "Current nucleic acid-based tests for active COVID-19 infection require expensive equipment suited to large, centralized diagnostic laboratories. Using the rapid-response funding, biology professor Martin Wu and his team will develop a simple, cheap and quick test based on a PCR “dipstick” technology. If successful, this new test can be deployed widely in communities for rapid, decentralized point-of-care diagnosis and epidemiological surveillance." Congratulations to Martin and his team! To learn more about the funding initiative, please click here to read the full article.
top of page
bottom of page